Genelux Research Development vs Net Income From Continuing Ops Analysis

GNLX Stock

2.72 0.01 0.37%

Genelux Common financial indicator trend analysis is much more than just examining Genelux Common latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Genelux Common is a good investment. Please check the relationship between Genelux Common Research Development and its Net Income From Continuing Ops accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genelux Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.

Research Development vs Net Income From Continuing Ops

Research Development vs Net Income From Continuing Ops Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Genelux Common Research Development account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Genelux Common's Research Development and Net Income From Continuing Ops is -0.55. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Genelux Common, assuming nothing else is changed. The correlation between historical values of Genelux Common's Research Development and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of Genelux Common are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Research Development i.e., Genelux Common's Research Development and Net Income From Continuing Ops go up and down completely randomly.

Correlation Coefficient

-0.55

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Research Development

Net Income From Continuing Ops

Most indicators from Genelux Common's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genelux Common current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genelux Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For more information on how to buy Genelux Stock please use our How to Invest in Genelux Common guide.At this time, Genelux Common's Issuance Of Capital Stock is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 71.45 in 2024, whereas Selling General Administrative is likely to drop slightly above 8.5 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	1.4M	1.4M	4.0M	4.2M
Depreciation And Amortization	895K	968K	1.0M	883.5K

Interest Expense Depreciation And Amortization

Genelux Common fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Long Term Debt	Capital Lease Obligations
Total Assets		-0.71	-0.98	-0.53	0.91	-0.49	0.55	-0.92	-0.93	0.22	0.79	0.58	-0.06	0.78	1.0	0.79	-0.64	0.5	0.89	-0.69	1.0	-0.39	-0.19	-0.88	-0.7	0.83
Short Long Term Debt Total	-0.71		0.63	0.81	-0.93	0.16	-0.86	0.91	0.6	0.16	-0.25	-0.53	0.35	-0.5	-0.72	-0.63	0.86	-0.07	-0.65	0.99	-0.7	0.64	-0.52	0.45	0.41	-0.63
Other Current Liab	-0.98	0.63		0.38	-0.85	0.64	-0.45	0.85	0.97	-0.36	-0.77	-0.62	-0.07	-0.87	-0.97	-0.8	0.64	-0.66	-0.92	0.59	-0.98	0.24	0.29	0.95	0.79	-0.89
Total Current Liabilities	-0.53	0.81	0.38		-0.76	-0.34	-0.86	0.79	0.23	0.63	-0.35	-0.04	0.77	-0.08	-0.57	-0.27	0.42	0.4	-0.35	0.86	-0.54	0.95	-0.59	0.09	-0.1	-0.23
Total Stockholder Equity	0.91	-0.93	-0.85	-0.76		-0.28	0.78	-1.0	-0.79	-0.01	0.57	0.58	-0.26	0.65	0.92	0.74	-0.8	0.25	0.81	-0.92	0.91	-0.59	0.21	-0.68	-0.56	0.76
Net Tangible Assets	-0.49	0.16	0.64	-0.34	-0.28		0.16	0.24	0.77	-0.79	-0.22	-0.53	-0.54	-0.8	-0.43	-0.61	0.46	-0.98	-0.58	0.04	-0.48	-0.41	0.53	0.84	0.82	-0.69
Property Plant And Equipment Net	0.55	-0.86	-0.45	-0.86	0.78	0.16		-0.8	-0.33	-0.5	0.34	0.36	-0.53	0.38	0.58	0.2	-0.6	-0.17	0.61	-0.88	0.55	-0.75	0.68	-0.21	-0.21	0.53
Net Debt	-0.92	0.91	0.85	0.79	-1.0	0.24	-0.8		0.77	0.08	-0.62	-0.51	0.33	-0.63	-0.93	-0.7	0.74	-0.21	-0.81	0.91	-0.92	0.65	-0.21	0.66	0.51	-0.73
Retained Earnings	-0.93	0.6	0.97	0.23	-0.79	0.77	-0.33	0.77		-0.53	-0.63	-0.69	-0.22	-0.89	-0.9	-0.86	0.7	-0.77	-0.88	0.54	-0.92	0.08	0.34	0.98	0.87	-0.9
Accounts Payable	0.22	0.16	-0.36	0.63	-0.01	-0.79	-0.5	0.08	-0.53		0.04	0.58	0.9	0.48	0.16	0.56	-0.3	0.81	0.26	0.23	0.2	0.78	-0.67	-0.6	-0.72	0.41
Cash	0.79	-0.25	-0.77	-0.35	0.57	-0.22	0.34	-0.62	-0.63	0.04		0.21	-0.14	0.56	0.81	0.34	-0.08	0.34	0.71	-0.27	0.81	-0.34	-0.42	-0.66	-0.43	0.57
Non Current Assets Total	0.58	-0.53	-0.62	-0.04	0.58	-0.53	0.36	-0.51	-0.69	0.58	0.21		0.57	0.72	0.53	0.65	-0.84	0.56	0.72	-0.49	0.55	0.25	0.02	-0.64	-0.89	0.81
Non Currrent Assets Other	-0.06	0.35	-0.07	0.77	-0.26	-0.54	-0.53	0.33	-0.22	0.9	-0.14	0.57		0.29	-0.13	0.24	-0.16	0.61	0.09	0.4	-0.09	0.93	-0.51	-0.3	-0.58	0.24
Other Assets	0.78	-0.5	-0.87	-0.08	0.65	-0.8	0.38	-0.63	-0.89	0.48	0.56	0.72	0.29		0.74	0.59	-0.65	0.84	0.94	-0.41	0.77	0.04	-0.24	-0.92	-0.92	0.98
Cash And Short Term Investments	1.0	-0.72	-0.97	-0.57	0.92	-0.43	0.58	-0.93	-0.9	0.16	0.81	0.53	-0.13	0.74		0.76	-0.61	0.45	0.87	-0.7	1.0	-0.45	-0.16	-0.84	-0.65	0.8
Common Stock Shares Outstanding	0.79	-0.63	-0.8	-0.27	0.74	-0.61	0.2	-0.7	-0.86	0.56	0.34	0.65	0.24	0.59	0.76		-0.76	0.55	0.59	-0.59	0.77	-0.07	-0.24	-0.79	-0.69	0.63
Non Current Liabilities Total	-0.64	0.86	0.64	0.42	-0.8	0.46	-0.6	0.74	0.7	-0.3	-0.08	-0.84	-0.16	-0.65	-0.61	-0.76		-0.39	-0.68	0.82	-0.62	0.16	-0.33	0.59	0.71	-0.76
Other Current Assets	0.5	-0.07	-0.66	0.4	0.25	-0.98	-0.17	-0.21	-0.77	0.81	0.34	0.56	0.61	0.84	0.45	0.55	-0.39		0.63	0.04	0.49	0.47	-0.61	-0.86	-0.86	0.73
Other Stockholder Equity	0.89	-0.65	-0.92	-0.35	0.81	-0.58	0.61	-0.81	-0.88	0.26	0.71	0.72	0.09	0.94	0.87	0.59	-0.68	0.63		-0.6	0.89	-0.21	-0.09	-0.87	-0.84	0.98
Total Liab	-0.69	0.99	0.59	0.86	-0.92	0.04	-0.88	0.91	0.54	0.23	-0.27	-0.49	0.4	-0.41	-0.7	-0.59	0.82	0.04	-0.6		-0.68	0.69	-0.55	0.38	0.33	-0.56
Total Current Assets	1.0	-0.7	-0.98	-0.54	0.91	-0.48	0.55	-0.92	-0.92	0.2	0.81	0.55	-0.09	0.77	1.0	0.77	-0.62	0.49	0.89	-0.68		-0.41	-0.19	-0.87	-0.68	0.82
Short Term Debt	-0.39	0.64	0.24	0.95	-0.59	-0.41	-0.75	0.65	0.08	0.78	-0.34	0.25	0.93	0.04	-0.45	-0.07	0.16	0.47	-0.21	0.69	-0.41		-0.53	-0.04	-0.3	-0.05
Common Stock	-0.19	-0.52	0.29	-0.59	0.21	0.53	0.68	-0.21	0.34	-0.67	-0.42	0.02	-0.51	-0.24	-0.16	-0.24	-0.33	-0.61	-0.09	-0.55	-0.19	-0.53		0.47	0.31	-0.1
Property Plant Equipment	-0.88	0.45	0.95	0.09	-0.68	0.84	-0.21	0.66	0.98	-0.6	-0.66	-0.64	-0.3	-0.92	-0.84	-0.79	0.59	-0.86	-0.87	0.38	-0.87	-0.04	0.47		0.89	-0.88
Long Term Debt	-0.7	0.41	0.79	-0.1	-0.56	0.82	-0.21	0.51	0.87	-0.72	-0.43	-0.89	-0.58	-0.92	-0.65	-0.69	0.71	-0.86	-0.84	0.33	-0.68	-0.3	0.31	0.89		-0.92
Capital Lease Obligations	0.83	-0.63	-0.89	-0.23	0.76	-0.69	0.53	-0.73	-0.9	0.41	0.57	0.81	0.24	0.98	0.8	0.63	-0.76	0.73	0.98	-0.56	0.82	-0.05	-0.1	-0.88	-0.92

Click cells to compare fundamentals

Genelux Common Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Genelux Stock Analysis

When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Genelux Research Development vs Net Income From Continuing Ops Analysis

Research Development vs Net Income From Continuing Ops

Research Development vs Net Income From Continuing Ops Correlation Analysis

Correlation Coefficient

Research Development

Net Income From Continuing Ops

Genelux Common fundamental ratios Correlations

Genelux Common Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Genelux Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 0.99	Short Long Term Debt Total
Property Plant Equipment	+ 0.98	Retained Earnings
Capital Lease Obligations	+ 0.98	Other Assets

Net Debt	- 1.0	Total Stockholder Equity
Other Current Assets	- 0.98	Net Tangible Assets
Total Current Assets	- 0.98	Other Current Liab
Other Current Liab	- 0.98	Total Assets
Cash And Short Term Investments	- 0.97	Other Current Liab
Cash And Short Term Investments	- 0.93	Net Debt